Frequently Asked Questions
The TM Flow device offers numerous benefits for medical practices, including non-invasive and accurate testing, early detection of autonomic and arterial dysfunctions, and comprehensive diagnostics that reduce the overall cost of patient care. Additionally, the device’s tests are easy to bill with multi-code diagnostics, making it a valuable investment for enhancing patient care and optimizing practice efficiency. It also supports compliance with standards of care recommended by leading health organizations.
Yes, the TM Flow device is covered by Medicare and most private pay carriers. Specific CPT codes, such as 95921 for cardiovagal innervation and 93923 for ankle-brachial pressure index, ensure that the diagnostics are easy to bill. Coverage and reimbursements may vary depending on the Medicare locality, but the comprehensive diagnostics offered by the TM Flow device are widely recognized and supported by insurance providers.
Autonomic nervous system testing is crucial for diabetes and cardiovascular patients because it helps in the early detection of autonomic neuropathy, which is a common complication in these conditions. Early detection through ANS testing allows for timely intervention and management, reducing the risk of further complications. The American Diabetes Association recommends ANS testing as a standard of care for patients with Type 1 and Type 2 diabetes, highlighting its importance in effective diabetes management.
The TM Flow device is an advanced, non-invasive diagnostic tool designed to perform a series of tests that aid in the identification and early detection of autonomic nervous system (ANS) and arterial dysfunctions. It provides quantitative assessments of the ANS, helping to distinguish between early and late stages of autonomic neuropathy. The TM Flow device is particularly valuable for cardiovascular and diabetic autonomic neuropathy (DAN) testing, making it an essential tool in diabetes management and cardiovascular assessments.
TM Flow in Portland
Although the TM Flow is a highly reimbursable diagnostic in Portland, OR, many practitioners do not know how to use it. This is because the TM Flow is a peripheral neuropathy diagnostic that has been used primarily by neurologists and neurophysiologists. The device is easy to learn and use so that anyone can take advantage of this cutting edge technology. The TM Flow offers the ability to diagnose patients with neuropathy early within the physician’s office before motor and sensory symptoms present themselves. The device was developed by Drs. Mark Rosenfeld and David Bock in 2002 as an alternative method for testing sudomotor function in patients who cannot or will not follow standard sudomotor testing protocols due to pain or discomfort associated with conventional techniques (such as pinprick testing).
The TM Flow can help you generate income by using existing patient flow
The TM Flow is a highly reimbursable diagnostic that can help you generate income by using existing patient flow. The TM Flow is the only peripheral neuropathy test that can be billed under 95921, 95923 and 93923. The TM Flow is simple to use and can be performed in a few minutes.
The TM Flow is a peripheral neuropathy diagnostic that can be billed under 95921, 95923 and 93923
The TM Flow is a highly reimbursable peripheral neuropathy diagnostic that can be billed under 95921, 95923 and 93923. The TM Flow is an electrodiagnostic test that uses the patient’s thumb or index finger to assess nerve function in their hands and arms.
Sudomotor testing has been standard of care for neuropathy diagnostics for many years. It is the best way to identify neuropathy early, before motor and sensory symptoms present.
Neuropathy is a progressive disease that causes pain, numbness, and tingling in the feet and hands. It can be caused by diabetes or other conditions.
Sudomotor testing has been standard of care for neuropathy diagnostics for many years. It is the best way to identify neuropathy early, before motor and sensory symptoms present themselves as pain and weakness.
The TM Flow offers a method of neuropathy testing that meets all CMS coverage criteria as well as ICD-10 coding requirements.
The TM Flow is a highly reimbursable diagnostic that meets all CMS coverage criteria as well as ICD-10 coding requirements. The TM Flow offers a method of neuropathy testing that can be used to diagnose neuropathy in any practice setting.
The TM Flow can be used to diagnose patients with neuropathy in any practice setting
The TM Flow can be used to diagnose patients with neuropathy in any practice setting.
If you are a chiropractor, physical therapist, occupational therapist or massage therapist who performs direct patient care and would like to expand your services by offering the TM Flow as a diagnostic tool, this article will give you the information needed to make an informed decision about whether it is right for your practice.
Conclusion
The TM Flow is a highly reimbursable diagnostic in Portland, OR. It can be used to diagnose patients with neuropathy in any practice setting and offers a method of neuropathy testing that meets all CMS coverage criteria as well as ICD-10 coding requirements. It is the best way to identify neuropathy early, before motor and sensory symptoms present.
RSS FEED
- The TM Flow is a highly reimbursable diagnostic in Portland, OR
- Pain Clinics in Albuquerque, NM Adopt the TM Flow as Gold Standard
- Neuropathy in Philadelphia, PA can be detected with the TM Flow device
- Pain Management Clinics in Dallas, TX are Using the TM Flow to Diagnose Symptoms
- Unlocking the Potential of ANS Testing: Insights for Healthcare Providers
- Neuropathy clinics in Savanah, GA use the TM Flow
- Come to Charleston, WV to Get a TM Flow
- How the TM Flow will maximize your physician practice in Boise Idaho
- Doctors in Pittsburg, PA are using the TM Flow for the treatment of neuropathy
- Which Patients Require ANS Testing?
